Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5622771 | Alzheimer's & Dementia | 2017 | 10 Pages |
â¢Brain-derived neurotrophic factor (BDNF) Val66Met interacts with SORL1 variants to impact expression of SORL1-005.â¢SORL1-005 may influence diffuse rather than neuritic amyloid pathology in postmortem brain.â¢The BDNF-SORL1 interaction effect is present in individuals without confirmed Alzheimer's disease.â¢In vivo amyloid, measured by positron emission tomography imaging, is also impacted by the BDNF-SORL1 interaction.
IntroductionThe brain-derived neurotrophic factor (BDNF) interacts with important genetic Alzheimer's disease (AD) risk factors. Specifically, variants within the SORL1 gene determine BDNF's ability to reduce amyloid β (Aβ) in vitro. We sought to test whether functional BDNF variation interacts with SORL1 genotypes to influence expression and downstream AD-related processes in humans.MethodsWe analyzed postmortem brain RNA sequencing and neuropathological data for 441 subjects from the Religious Orders Study/Memory and Aging Project and molecular and structural neuroimaging data for 1285 subjects from the Alzheimer's Disease Neuroimaging Initiative.ResultsWe found one SORL1 RNA transcript strongly regulated by SORL1-BDNF interactions in elderly without pathological AD and showing stronger associations with diffuse than neuritic Aβ plaques. The same SORL1-BDNF interactions also significantly influenced Aβ load as measured with [18F]Florbetapir positron emission tomography.DiscussionOur results bridge the gap between risk and resilience factors for AD, demonstrating interdependent roles of established SORL1 and BDNF functional genotypes.